Cardiac risk factor awareness and management in patients with systemic lupus erythematosus

Arthritis Care and Research

Volumn 51, Issue 6, 2004, Pages 983-988

  Costenbader, Karen H ^a   Wright, Elizabeth ^a   Liang, Matthew H ^a   Karlson, Elizabeth W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiac risk factor; Compliance; Coronary artery disease; Systemic lupus erythematosus

Indexed keywords

ANTIRHEUMATIC AGENT; CHOLESTEROL;

ADULT; AWARENESS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFESTYLE; MALE; MEDICAL DOCUMENTATION; OBESITY; OUTPATIENT; PERCEPTION; PHYSICAL ACTIVITY; PHYSICIAN; QUESTIONNAIRE; RELIABILITY; REVIEW; RHEUMATOLOGY; RISK ASSESSMENT; SELF REPORT; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ATTITUDE TO HEALTH; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE STYLE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; OBESITY; PATIENT COMPLIANCE; QUESTIONNAIRES; RISK FACTORS; SINGLE-BLIND METHOD; SMOKING;

EID: 10644269385     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20824     Document Type: Review

References (45)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
2. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL. Systemic lupus erythematosus - survival patterns: experience with 609 patients. JAMA 1981;245:934-8.
3. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982;25:601-11.
4. Ginzler E, Berg A. Mortality in systemic lupus erythematosus. J Rheumatol 1987;14 Suppl 13:218-22.
5. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987;14 Suppl 13:223-26.
6. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612-17.
7. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. QJM 1985;55:87-98.
8. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus: long-term followup of an inception cohort. Arthritis Rheum 1995;38:1492-99.
9. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
10. Hosenpud JD, Montanaro A, Hart MV, Haines JE, Specht HD, Bennett RM, et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984;77:286-92.
11. Shome GP, Sakauchi M, Yamane K, Takemura H, Kashiwagi H. Ischemic heart disease in systemic lupus erythematosus: a retrospective study of 65 patients treated with prednisolone. Jpn J Med 1989;28:599-603.
12. Bulkley BH, Roberts W. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975;58: 243-64.
13. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981;70:775-81.
14. Kong TQ, Kellum RE, Haserik JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: a correlation of clinical and autopsy findings in thirty patients. Circulation 1962;26:7-11.
15. Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients and preventive practices. Medicine (Baltimore) 1992;71:291-302.
16. Petri M, Perez-Guttman S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-19.
17. DeInocencio J, Lovell DJ. Cardiac function in systemic lupus erythematosus. J Rheumatol 1994;21:2147-56.
18. Leong KH, Koh ET, Feng PH, Boey ML. Lipid profiles in systemic lupus erythematosus. J Rheumatol 1994;21:1264-7.
19. Bruce IN, Urowitz MB, Gladman DD, Hallett DC. The natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 1999;26:2137-43.
20. Formiga F, Meco JF, Pinto X, Jacob J, Moga I, Pujol R. Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients. Lupus 2001;10:359-63.
21. Hallegua DS, Wallace DJ. How accelerated atherosclerosis in SLE has changed our management of the disorder. Lupus 2000;9:228-31.
22. Lockshin MD, Salmon JE, Roman MJ. Atherosclerosis and lupus: a work in progress [editorial]. Arthritis Rheum 2001; 44:2215-7.
23. Aranow C, Ginzler EM. Coronary artery disease in SLE: high suspicion leads to early recognition. J Musculoskel Med 2000; 17:473-82.
24. Salmon JE, Roman MJ. Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Curr Opin Rheumatol 2001;13:341-4.
25. Bruce IN, Gladman DD, Urowitz MB. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study. Clin Exp Rheumatol 1998;16:435-40.
26. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study. Arthritis Rheum 2003;48:3159-67.
27. Daltroy LH, Eaton HM, Phillips CB, Karlson EW, Kaul H, Kinney GL, et al. Patient-partner communication, social support, and self-efficacy for lupus management: preliminary results [abstract]. Arthritis Care Res 1999;12:S23.
28. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-7.
30. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989;32:37-44.
31. Finucane FF, Freid VM. J. H. M. plan and operation of the National Health and Nutrition Examination Survey I Epidemiologic Followup Study, 1986. Hyattsville (MD): National Center for Health Statistics Vital Health Stat DHHS; 1990. Publication PHS. p. 90-1307.
32. Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda (MD): National Heart, Lung and Blood Institute. National High Blood Pressure Education Program; 1997.
33. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
34. American Diabetes Association: report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999;22:S5-19.
35. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
36. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000;9:170-5.
37. Al-Herz A, Ensworth S, Shojania K, Esdaile JM. Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol 2003;30:493-6.
38. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92.
39. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-20.
40. Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med 2002;112:603-9.
41. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
42. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
43. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15.
44. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
45. Pereira MA, FitzerGerald SJ, Gregg EW, Joswiak ML, Ryan WJ, Suminski RR, et al. A collection of Physical Activity Questionnaires for health-related research. Med Sci Sports Exerc 1997;29:S1-205.